Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Nephrons

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Acute Kidney Injury II: Pathophysiology

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...

Renal Corpuscle

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[<sup>68</sup>Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX).

European journal of nuclear medicine and molecular imaging·2026

Same author

Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025

Same author

Unraveling the Puzzle of Bone Health in Klinefelter Syndrome: Association Between DXA-Derived Lumbar Bone Strain Index and Body Composition Parameters in a Single Center Cohort.

Clinical endocrinology·2025

Same author

Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study).

Cancers·2025

Same author

Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies.

European journal of endocrinology·2024

Same author

Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey.

Journal of clinical medicine·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Nephrogenic systemic fibrosis an unsolved riddle.

Giorgio Graziani¹, Alessandro Montanelli, Simona Brambilla

¹Nephrology and Dialysis Unit, Department of Internal Medicine, IRCCS Istituto Clinico Humanitas, Rozzano, Milano, Italy. giorgio.graziani@humanitas.it

Journal of Nephrology

|April 23, 2009

Summary

This summary is machine-generated.

Nephrogenic systemic fibrosis (NSF) is a serious skin condition linked to Gadolinium contrast agents. While the exact cause is debated, NSF risk remains low, especially compared to risks from iodinated contrast media.

More Related Videos

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

Area of Science:

Nephrology
Radiology
Toxicology

Background:

Nephrogenic systemic fibrosis (NSF) is a severe scleroderma-like disease causing dermal fibrosis.
Approximately 215 NSF cases are documented, primarily associated with Gadolinium-based contrast agents (GBCAs) used in Magnetic Resonance Imaging (MRI).
The precise pathogenesis and triggers of NSF remain unclear, with ongoing debate regarding the role of Gadolinium exposure.

Purpose of the Study:

To review the current understanding of Nephrogenic Systemic Fibrosis (NSF) pathogenesis.
To evaluate the association between Gadolinium contrast agents and NSF in patients with kidney disease.
To compare the risks of NSF with other contrast-induced renal complications.

Main Methods:

Review of existing literature on NSF, Gadolinium contrast agents, and end-stage renal disease (ESRD).
Analysis of reported NSF cases and epidemiological data.
Discussion of proposed pathogenetic mechanisms, including Gadolinium toxicity and transmetallation theory.

Main Results:

Gadolinium exposure, particularly in end-stage renal disease (ESRD) and hemodialysis (HD) patients, is strongly linked to NSF, though a definitive cause-effect relationship is not established.
Alternative theories suggest a role for lanthanum carbonate, another rare earth element, in the geographical distribution of NSF.
The prevalence of NSF in at-risk populations is low, ranging from 0.4% to 0.7%.

Conclusions:

The exact cause of Nephrogenic Systemic Fibrosis (NSF) is still under investigation, with Gadolinium contrast agents being a primary suspect.
While Gadolinium-induced NSF is a concern, its prevalence is significantly lower than the risks associated with iodinated contrast media in patients with impaired renal function.
Nephrologists should counsel patients on the relative risks, emphasizing that iodinated contrast media pose a greater risk of renal impairment than GBCAs pose for NSF.